Pachychoroid Spectrum Disorders: An Updated Review
暂无分享,去创建一个
[1] K. Falavarjani,et al. Differentiating a pachychoroid and healthy choroid using an unsupervised machine learning approach , 2022, Scientific Reports.
[2] A. Tsujikawa,et al. Choriocapillaris flow deficit in a pachychoroid spectrum disease using en face optical coherence tomography angiography averaging , 2022, PloS one.
[3] Xiongze Zhang,et al. Detection of pachychoroid neovasculopathy with optical coherence tomography angiography versus dye angiography imaging. , 2022, Photodiagnosis and photodynamic therapy.
[4] S. Demirel,et al. A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy , 2022, Life.
[5] A. Invernizzi,et al. Imaging-based Assessment of Choriocapillaris: A Comprehensive Review , 2022, Seminars in ophthalmology.
[6] R. Adelman,et al. A case of extrafoveal focal choroidal excavation , 2022, American Journal of Ophthalmology Case Reports.
[7] C. Cheung,et al. Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy , 2022, Journal of clinical medicine.
[8] H. Akiyama,et al. Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy , 2022, Cureus.
[9] Peng Yan,et al. Updated review: optical coherence tomography findings of the pachychoroid disease spectrum. , 2022, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[10] A. Tsujikawa,et al. Natural Course of Pachychoroid Pigment Epitheliopathy , 2022, Ophthalmology science.
[11] Mengyang Li,et al. Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up , 2022, BMC Ophthalmology.
[12] J. Chhablani,et al. Accommodation Is Decreased in Eyes with Acute Central Serous Chorioretinopathy , 2022, Optometry and vision science : official publication of the American Academy of Optometry.
[13] S. Demirel,et al. Visualization of Type-1 Macular Neovascularization Secondary to Pachychoroid Spectrum Diseases: A Comparative Study for Sensitivity and Specificity of Indocyanine Green Angiography and Optical Coherence Tomography Angiography , 2022, Diagnostics.
[14] I. Georgalas,et al. Peripapillary Pachychoroid Syndrome (PPS): Diagnosing and Treating a Rare Entity , 2022, Case reports in ophthalmological medicine.
[15] S. Kishi,et al. A new insight into pachychoroid diseases: Remodeling of choroidal vasculature , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] S. Priglinger,et al. Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy. , 2022, Ophthalmology. Retina.
[17] Jaeryung Oh,et al. Factors related to the location of pigment epithelial detachment in central serous chorioretinopathy , 2022, Scientific Reports.
[18] O. Meijer,et al. Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities , 2022, Acta ophthalmologica.
[19] Shanna C. Yeung,et al. The effect of systemic and topical ophthalmic medications on choroidal thickness: A review , 2022, British journal of clinical pharmacology.
[20] Jano van Hemert,et al. Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy , 2022, Graefe's Archive for Clinical and Experimental Ophthalmology.
[21] D. Sarraf,et al. An unusual presentation of peripapillary pachychoroid syndrome , 2022, American journal of ophthalmology case reports.
[22] K. Freund,et al. Ultra-Widefield Indocyanine Green Angiography Reveals Patterns of Choroidal Venous Insufficiency Influencing Pachychoroid Disease , 2022, Investigative ophthalmology & visual science.
[23] A. Casuccio,et al. Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept , 2021, International Ophthalmology.
[24] S. Sivaprasad,et al. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders , 2021, Progress in Retinal and Eye Research.
[25] Ratnesh Ranjan,et al. Photodynamic therapy for peripapillary pachychoroid syndrome-a case report. , 2022, Digital journal of ophthalmology : DJO.
[26] G. Cennamo,et al. Structural and Vascular Changes of the Choroid in Polypoidal Choroidal Vasculopathy after Intravitreal Anti-VEGF Therapy , 2021, Ophthalmologica.
[27] F. Behar-Cohen,et al. Potential Treatment for Peripapillary Pachychoroid Syndrome , 2021, RETINAL Cases & Brief Reports.
[28] A. Young,et al. The Contemporary Role of Photodynamic Therapy in the Treatment of Pachychoroid Diseases , 2021, Journal of ophthalmology.
[29] A. Orlin,et al. Primary and secondary focal choroidal excavation morphologic phenotypes, associated ocular disorders and prognostic implications , 2021, British Journal of Ophthalmology.
[30] M. Lupidi,et al. One-year outcome of cystoid macular degeneration in central serous chorioretinopathy , 2021, European journal of ophthalmology.
[31] F. Wen,et al. CORRELATION BETWEEN FOCAL CHOROIDAL EXCAVATION AND UNDERLYING RETINOCHOROIDAL DISEASE , 2021, Retina.
[32] A. Tsujikawa,et al. Pachychoroid‐phenotype effects on 5‐year visual outcomes of anti‐VEGF monotherapy in polypoidal choroidal vasculopathy , 2021, Acta ophthalmologica.
[33] T. Kawano,et al. Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.
[34] B. Takkar,et al. Pachychoroid neovasculopathy: A comparative review on pathology, clinical features, and therapy , 2021, European journal of ophthalmology.
[35] Ratnesh Ranjan,et al. Posterior choroidal fluid loculation in central serous chorioretinopathy presenting as a choroidal elevation: A rare Pachychoroid phenotype , 2021, European journal of ophthalmology.
[36] A. Loewenstein,et al. Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study , 2021, Eye.
[37] P. Sen,et al. A case of peripapillary pachychoroid syndrome treated with anti-vascular endothelial growth factor injections , 2021 .
[38] S. Demirel,et al. A comparative study on the choroidal vascularity index and the determination of cut-off values in the pachychoroid spectrum diseases , 2021, Japanese Journal of Ophthalmology.
[39] Jaeryung Oh,et al. Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile , 2021, Scientific Reports.
[40] R. Agrawal,et al. Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates , 2021, Investigative ophthalmology & visual science.
[41] S. Sadda,et al. Long-term visual and anatomic outcomes of patients with peripapillary pachychoroid syndrome , 2020, British Journal of Ophthalmology.
[42] J. Chhablani,et al. PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY-A NEW ADDITION TO THE SPECTRUM OF PACHYCHOROID DISEASE? , 2020, Retina.
[43] Gabriella Moraes,et al. Pachychoroid spectrum disease , 2020, Acta ophthalmologica.
[44] A. Tsujikawa,et al. Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration , 2020, Scientific Reports.
[45] R. Spaide,et al. Intervortex Venous Anastomosis in Pachychoroid-Related Disorders. , 2020, Retina.
[46] J. Chae,et al. Choroidal inflammation and choriocapillaris ischemia in focal choroidal excavation in comparison to pachychoroid neovasculopathy. , 2020, Retina.
[47] R. Spaide,et al. Choriocapillaris Vascular Parameters in Normal Eyes and Those with Pachychoroid with and without Disease. , 2020, Retina.
[48] T. Lai,et al. Pachychoroid: current concepts on clinical features and pathogenesis , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[49] V. Castro Navarro,et al. Peripapillary pachychoroid neovasculopathy: A novel entity , 2020, European journal of ophthalmology.
[50] R. Chawla,et al. Focal choroidal excavation: review of literature , 2020, British Journal of Ophthalmology.
[51] H. Koizumi,et al. Scleral Thickness in Central Serous Chorioretinopathy. , 2020, Ophthalmology. Retina.
[52] S. Yzer,et al. Treatment of Peripapillary Pachychoroid Syndrome , 2020 .
[53] D. Maltsev,et al. Effect of Topical Pilocarpine on Choroidal Thickness in Healthy Subjects , 2020, Optometry and vision science : official publication of the American Academy of Optometry.
[54] T. Nakazawa,et al. Systemic oxidative stress level in patients with central serous chorioretinopathy , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[55] S. Kishi,et al. Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. , 2020, Ophthalmology. Retina.
[56] K. Vupparaboina,et al. Anterior Sclera Undergoes Thinning with Increasing Degree of Myopia , 2020, Investigative ophthalmology & visual science.
[57] Tatsuya Inoue,et al. One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.
[58] J. Sambricio,et al. Diagnosis by multimodal imaging in peripapillary pachychoroid syndrome: A case report. , 2020 .
[59] M. Morimoto,et al. One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions , 2020, Japanese Journal of Ophthalmology.
[60] Soo Ick Cho,et al. Association of Irregular Pigment Epithelial Detachment in Central Serous Chorioretinopathy with Genetic Variants Implicated in Age-related Macular Degeneration , 2020, Scientific Reports.
[61] K. Freund,et al. RELATIONSHIP BETWEEN CHOROIDAL VASCULAR HYPERPERMEABILITY, CHORIOCAPILLARIS FLOW DENSITY, AND CHOROIDAL THICKNESS IN EYES WITH PACHYCHOROID PIGMENT EPITHELIOPATHY. , 2020, Retina.
[62] Cheng-Kuo Cheng,et al. DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. , 2020, Retina.
[63] C. Hoyng,et al. CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2019, Retina.
[64] C. Sotozono,et al. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy , 2019, British Journal of Ophthalmology.
[65] R. Tadayoni,et al. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes , 2019, British Journal of Ophthalmology.
[66] C. Jin,et al. Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.
[67] S. Kishi,et al. Remodeling of macular vortex veins in pachychoroid neovasculopathy , 2019, Scientific Reports.
[68] D. Kumawat,et al. Pachychoroid Spectrum Disorders: A Review of Clinical Features and Management , 2019, Delhi Journal of Ophthalmology.
[69] Kiran Kumar Vupparaboina,et al. Choroidal imaging biomarkers. , 2019, Survey of ophthalmology.
[70] W. Lee,et al. Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy , 2019, Scientific Reports.
[71] J. Chhablani,et al. Management of chronic central serous chorioretinopathy , 2018, Indian journal of ophthalmology.
[72] S. Sonoda,et al. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy , 2018, PloS one.
[73] You-xin Chen,et al. Choroid changes in vortex vein-occluded monkeys. , 2018, International journal of ophthalmology.
[74] Hyewon Chung,et al. Changes in Stromal and Luminal Areas of the Choroid in Pachychoroid Diseases: Insights Into the Pathophysiology of Pachychoroid Diseases. , 2018, Investigative ophthalmology & visual science.
[75] W. Lee,et al. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.
[76] M. Ersoz,et al. Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.
[77] C. Sotozono,et al. Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration , 2018, Scientific Reports.
[78] J. Caminal,et al. Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy. , 2018, Investigative ophthalmology & visual science.
[79] L. Yannuzzi,et al. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of ‘expanded spectra’ – a review , 2017, Clinical & experimental ophthalmology.
[80] P. Keane,et al. PERIPAPILLARY PACHYCHOROID SYNDROME , 2017, Retina.
[81] Min Zhao,et al. SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY , 2015, Retina.
[82] H. Iijima,et al. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2017, Retina.
[83] Y. Teo,et al. Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians , 2017, Journal of Human Genetics.
[84] A. Loewenstein,et al. Eplerenone for chronic central serous chorioretinopathy–a randomized controlled prospective study , 2017, Acta ophthalmologica.
[85] Shibo Tang,et al. Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis , 2017, International Journal of Clinical Pharmacy.
[86] C. Cheung,et al. Choroidal structures in polypoidal choroidal vasculopathy, neovascular age-related maculopathy, and healthy eyes determined by binarization of swept source optical coherence tomographic images , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.
[87] Yoneyama Seigo,et al. ポリープ状脈絡膜血管症におけるpachychoroid neovasculopathyの遺伝的・臨床的特徴 , 2017 .
[88] A. Tsujikawa,et al. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration. , 2017, Investigative ophthalmology & visual science.
[89] K. Freund,et al. CHOROIDAL MORPHOLOGY IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY AND NORMAL OR SUBNORMAL SUBFOVEAL CHOROIDAL THICKNESS , 2016, Retina.
[90] R. Agrawal,et al. CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY , 2016, Retina.
[91] S. Sonoda,et al. Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy , 2016, British Journal of Ophthalmology.
[92] W. Lee,et al. ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID , 2016, Retina.
[93] K. Freund,et al. EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.
[94] T. Wong,et al. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study , 2016, Scientific Reports.
[95] K Bailey Freund,et al. Optical Coherence Tomography Angiography of Shallow Irregular Pigment Epithelial Detachments In Pachychoroid Spectrum Disease. , 2015, American journal of ophthalmology.
[96] A. Tsujikawa,et al. Pachychoroid neovasculopathy and age-related macular degeneration , 2015, Scientific Reports.
[97] A. Trost,et al. Lymphatic Markers in the Adult Human Choroid. , 2015, Investigative ophthalmology & visual science.
[98] F. Koch,et al. Randomized Clinical Trial to Compare Micropulse Photocoagulation Versus Half-dose Verteporfin Photodynamic Therapy in the Treatment of Central Serous Chorioretinopathy. , 2015, Ophthalmic surgery, lasers & imaging retina.
[99] Robert P. Cubbidge,et al. Measurement of Scleral Thickness in Humans Using Anterior Segment Optical Coherent Tomography , 2015, PloS one.
[100] M. Yuzawa,et al. MORPHOLOGIC FEATURES OF FOCAL CHOROIDAL EXCAVATION ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY WITH SIMULTANEOUS ANGIOGRAPHY , 2014, Retina.
[101] F. Türkçü,et al. Psychological Distress and Poor Quality of Life in Patients with Central Serous Chorioretinopathy , 2014, Seminars in ophthalmology.
[102] F. Geiser,et al. Temperament and Character Personality Profile and Illness-Related Stress in Central Serous Chorioretinopathy , 2014, TheScientificWorldJournal.
[103] Yoo-Ri Chung,et al. Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review , 2013, Eye.
[104] A. Tsujikawa,et al. Focal choroidal excavation in eyes with central serous chorioretinopathy. , 2013, American journal of ophthalmology.
[105] James G Fujimoto,et al. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. , 2013, Ophthalmology.
[106] H. Enaida,et al. Symptomatic and Morphological Differences between Choroidal Excavations , 2013, Optometry and vision science : official publication of the American Academy of Optometry.
[107] K. Freund,et al. PERIPHERAL POLYPOIDAL CHOROIDAL VASCULOPATHY AS A CAUSE OF PERIPHERAL EXUDATIVE HEMORRHAGIC CHORIORETINOPATHY: A Report of 10 Eyes , 2013, Retina.
[108] G. Yılmaz,et al. Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy , 2013, Eye.
[109] L. Yannuzzi,et al. TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2012, Retina.
[110] I. Mantel,et al. Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications. , 2012, American journal of ophthalmology.
[111] L. Yannuzzi. TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.
[112] Michael D. Ober,et al. The expanded spectrum of focal choroidal excavation. , 2011, Archives of ophthalmology.
[113] T. Higashide,et al. Unilateral choroidal excavation in the macula detected by spectral‐domain optical coherence tomography , 2009, Acta ophthalmologica.
[114] R. Spaide,et al. ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.
[115] C. Shields,et al. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes. , 2009, Ophthalmology.
[116] T. Lai,et al. SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: One-Year Results of a Prospective Study , 2008, Retina.
[117] M. Mandai,et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.